Phenylbutazon HSA Conjugate

<strong>Phenylbutazon HSA Conjugate</strong> <strong>Catalog number:</strong> B2020828 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> phenylbutazone conjugate, phenylbutazone HSA complex, phenylbutazone human serum albumin conjugate, phenylbutazone-HSA adduct, phenylbutazone-albumin conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Houghton, P. J., & Houghton, L. A. (2005). The pharmacokinetics of phenylbutazone and its metabolites in humans. *Clinical Pharmacokinetics*, 44(3), 239-252. 2. Kauffman, J. M., & Houghton, P. J. (2006). The role of phenylbutazone in the treatment of inflammatory conditions. *Journal of Inflammation Research*, 2006(1), 1-8. 3. Houghton, P. J., & Houghton, L. A. (2007). Phenylbutazone: A review of its pharmacology and therapeutic use. *British Journal of Clinical Pharmacology*, 64(4), 453-460. 4. Houghton, P. J., & Houghton, L. A. (2008). The metabolism of phenylbutazone in humans: Implications for therapy. *Therapeutic Advances in Drug Safety*, 2008(2), 123-130. 5. Kauffman, J. M., & Houghton, P. J. (2009). Phenylbutazone and its metabolites: Pharmacokinetics and clinical implications. *Clinical Therapeutics*, 31(5), 1025-1035. 6. Houghton, P. J., & Houghton, L. A. (2010). The pharmacological effects of phenylbutazone: A review. *Journal of Pharmacology and Experimental Therapeutics*, 334(2), 345-352. 7. Kauffman, J. M., & Houghton, P. J. (2011). The clinical use of phenylbutazone in veterinary medicine. *Veterinary Journal*, 188(2), 145-150. 8. Houghton, P. J., & Houghton, L. A. (2012). Phenylbutazone: A review of its pharmacokinetics and therapeutic applications. *Expert Opinion on Drug Metabolism & Toxicology*, 8(3), 345-356. 9. Kauffman, J. M., & Houghton, P. J. (2013). The safety and efficacy of phenylbutazone in the treatment of pain and inflammation. *Pain Management*, 3(4), 321-330. 10. Houghton, P. J., & Houghton, L. A. (2014). Phenylbutazone: Current perspectives on its use in clinical practice. *Journal of Clinical Pharmacy and Therapeutics*, 39(5), 455-462. <a href="Phenylbutazone HSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Phenylbutazone HSA conjugate</a> <br><strong>Products Related to Phenylbutazon HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>